• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Emerg Infect Dis . SARS-CoV-2 Variants in Immunocompromised Patient Given Antibody Monotherapy

tetano

Editor, Senior Moderator
Emerg Infect Dis


. 2021 Aug 5;27(10).
doi: 10.3201/eid2710.211509. Online ahead of print.
SARS-CoV-2 Variants in Immunocompromised Patient Given Antibody Monotherapy

Aurélie Truffot, Julien Andréani, Marion Le Maréchal, Alban Caporossi, Olivier Epaulard, Raphaele Germi, Pascal Poignard, Sylvie Larrat

Abstract

A 72-year-old immunocompromised man infected with severe acute respiratory syndrome coronavirus 2 received bamlanivimab monotherapy. Viral evolution was monitored in nasopharyngeal and blood samples by melting curve analysis of single-nucleotide polymorphisms and whole-genome sequencing. Rapid emergence of spike receptor binding domain mutations was found, associated with a compartmentalization of viral populations.

Keywords: COVID-19; SARS-CoV-2; bamlanivimab; compartmentalization; coronavirus disease; coronaviruses; immunotherapy; monoclonal antibody; monotherapy; respiratory infections; selection; severe acute respiratory syndrome coronavirus 2; variants; viruses; whole-genome sequencing; zoonoses.
 
Back
Top Bottom